In our line of work, we see back pain everyday. Our clients have back pain, our employees have back pain, and we have back pain. In fact, back pain is one of the most common excuses to miss work or...
Guidant Initiates Worldwide Physician Communications Regarding Important Safety Information and Corrective Action about Implantable Cardiac Defibrillators
Guidant Corporation is voluntarily advising physicians about important safety information regarding certain devices. Guidant has apprised FDA of these actions, and FDA has indicated that it will classify them as recalls. These communications advise physicians and their patients of safety information and are intended to limit adverse events. Physicians should use this information to decide how...
FDA Issues Nationwide Notification of Recall of Certain Guidant Implantable Defibrillators and Cardiac Resynchronization Therapy Defibrillators
FDA is notifying health care providers and patients that the Guidant Corporation is recalling certain of its implantable defibrillators and cardiac resynchronization therapy defibrillators. These devices can develop an internal short circuit without warning, resulting in failure to deliver a shock when needed.
Medical device maker Guidant Corporation has announced a series of recalls culminating in a September 22, 2005 recall, recalling nearly 100,000 implanted defibrillators and pacemakers because of potential electrical malfunctions. The defect essentially places patients at risk as a result of an internal short circuit which comes without warning and can either result in a failure to deliver a...
Every year there are approximately one and a half million new surgical procedures known as Allografts - surgical transfers of bone, skin, tendons, and other tissues in which tissues from cadavers are transplanted into patients.Recently, the New Jersey tissue company known as Biomedical Tissue Services was criminally indicted for illegally harvesting human tissue from corpses. Biomedical then...
Boston Scientific announced earlier this month that it has set aside $381 million in anticipation of lawsuits stemming from faulty Guidant defibrillators and pacemakers. Boston Sci inherited Guidant's legal problems when it bought the company earlier this year for $27 billion.Included in the fallout are about 72 product liability class action lawsuits and about 477 individual lawsuits. The suits...
- Home & Family